Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 221

Sort by

Sort Order Select

Meeting Abstracts

1787-PUB: An Increased Risk of Metabolic Syndrome in Type 2 Diabetes Mellitus Patients Is Suggested by a High TG/HDL Ratio—A Retrospective Study

ASHISH K. SAXENA, MUKULESH GUPTA, MEENAKSHISUNDARAM LAKSHMANAN, RAKA SHEOHARE, BIJAY PATNI, MOHSIN ASLAM, ANUJ MAHESHWARI, NAGENDRA K. SINGH, VINAYAK S. HIREMATH, S. S. DARIYA, AASHNA PATIL, SURAJEET K. PATRA, DINESH KUMAR, RAMA REGULLA

Diabetes 2023;72(Supplement_1):1787-PUB

https://doi.org/10.2337/db23-1787-PUB

Published: 23 June 2023

View article titled, 1787-PUB: An Increased Risk of Metabolic Syndrome in Type 2 Diabetes Mellitus Patients Is Suggested by a High TG/HDL Ratio—A Retrospective Study

Meeting Abstracts

1623-P: Identification of Gut Microbes That Prevents Metabolic Syndrome in Healthy Japanese Adults

HISAE HONOKI, SHIHO FUJISAKA, YOSHIYUKI WATANABE, MAKITO OKU, YUKI KONDO, AYUMI NISHIMURA, TOMONOBU KADO, MUHAMMAD BILAL, ASAKO ENKAKU, AKIKO TAKIKAWA, DAISUKE CHUJO, YOSHITOMO MORINAGA, KAZUYUKI TOBE

Diabetes 2023;72(Supplement_1):1623-P

https://doi.org/10.2337/db23-1623-P

Published: 20 June 2023

View article titled, 1623-P: Identification of Gut Microbes That Prevents Metabolic Syndrome in Healthy Japanese Adults

Meeting Abstracts

321-OR: Differential Associations of Obesity and Metabolic Syndrome with Polyneuropathy in Early Type 2 Diabetes and Normal Glucose Tolerance

GUNDEGA SIPOLA, ALEXANDER STROM, MARIA BOMBRICH, ROBERT WAGNER, DAN ZIEGLER, MICHAEL RODEN, GIDON J. BÖNHOF, GDS GROUP

Diabetes 2023;72(Supplement_1):321-OR

https://doi.org/10.2337/db23-321-OR

Published: 20 June 2023

View article titled, 321-OR: Differential Associations of Obesity and Metabolic Syndrome with Polyneuropathy in Early Type 2 Diabetes and Normal Glucose Tolerance

Meeting Abstracts

1538-P: Brain TGFß Regulates Glucose Tolerance in Male Mice with Metabolic Syndrome

MONA ELGAZZAZ, KEVIN MIAO, ANNA R. NUZZO, LUKE RESTIVO, KARL MOLES, ERIC D. LAZARTIGUES

Diabetes 2023;72(Supplement_1):1538-P

https://doi.org/10.2337/db23-1538-P

Published: 20 June 2023

View article titled, 1538-P: Brain TGFß Regulates Glucose Tolerance in Male Mice with Metabolic Syndrome

Meeting Abstracts

1721-P: Patients with Metabolic Syndrome Are at Risk of Renal Outcome in CKD Stages 1-4 Regardless of Diabetes

HUGO Y.H. LIN, KAI-TING CHANG

Diabetes 2023;72(Supplement_1):1721-P

https://doi.org/10.2337/db23-1721-P

Published: 20 June 2023

View article titled, 1721-P: Patients with Metabolic Syndrome Are at Risk of Renal Outcome in CKD Stages 1-4 Regardless of Diabetes

Meeting Abstracts

1719-P: Nomogram for Predicting Remission of Metabolic Syndrome One Year after Sleeve Gastrectomy Surgery in Chinese Patients with Obesity

YUNHUI PAN, XIAODONG HAN, YINFANG TU, PIN ZHANG, HAOYONG YU, YUQIAN BAO

Diabetes 2023;72(Supplement_1):1719-P

https://doi.org/10.2337/db23-1719-P

Published: 20 June 2023

View article titled, 1719-P: Nomogram for Predicting Remission of Metabolic Syndrome One Year after Sleeve Gastrectomy Surgery in Chinese Patients with Obesity

Meeting Abstracts

590-P: Assessment of a Comprehensive Physical Fitness Index to Predict Future Diabetes Mellitus (DM) and Metabolic Syndrome (MetS)

TAKAAKI SATO, KAZUYA FUJIHARA, MAYUKO H. YAMADA, YUTA YAGUCHI, MASAHIKO YAMAMOTO, MASARU KITAZAWA, HAJIME ISHIGURO, TAEKO OSAWA, TAKAHO YAMADA, KIMINORI KATO, HIROHITO SONE

Diabetes 2023;72(Supplement_1):590-P

https://doi.org/10.2337/db23-590-P

Published: 20 June 2023

View article titled, 590-P: Assessment of a Comprehensive Physical Fitness Index to Predict Future Diabetes Mellitus (DM) and Metabolic Syndrome (MetS)

Meeting Abstracts

157-OR: Cystatin C Predicts Major Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients With and among Those Without the Metabolic Syndrome

ARTHUR MADER, MAXIMILIAN MAECHLER, BARBARA LARCHER, LUKAS SPRENGER, ANDREAS LEIHERER, AXEL MUENDLEIN, ALEXANDER VONBANK, THOMAS PLATTNER, HEINZ DREXEL, CHRISTOPH H. SAELY

Diabetes 2023;72(Supplement_1):157-OR

https://doi.org/10.2337/db23-157-OR

Published: 20 June 2023

View article titled, 157-OR: Cystatin C Predicts Major Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients With and among Those Without the Metabolic Syndrome

Meeting Abstracts

1239-P: The Time Point of Blood Pressure Measurement Rather than the Application of U.S. vs. European Blood Pressure Categorizations Is Important for Cardiovascular Risk Prediction in Patients with the Metabolic Syndrome

ANDREAS LEIHERER, WOLFGANG BROZEK, AXEL MUENDLEIN, HANNO ULMER, CHRISTOPH H. SAELY, THOMAS PLATTNER, ALEXANDER VONBANK, ARTHUR MADER, LUKAS SPRENGER, MAXIMILIAN MAECHLER, BARBARA LARCHER, PETER FRAUNBERGER, GABRIELE NAGEL, EMANUEL ZITT, HEINZ DREXEL, HANS CONCIN

Diabetes 2023;72(Supplement_1):1239-P

https://doi.org/10.2337/db23-1239-P

Published: 20 June 2023

View article titled, 1239-P: The Time Point of Blood Pressure Measurement Rather than the Application of U.S. vs. European Blood Pressure Categorizations Is Important for Cardiovascular Risk Prediction in Patients with the Metabolic Syndrome

Meeting Abstracts

1678-P: B6-Alms1-del Mice, a Metabolic Syndrome Animal Model, Shows Semaglutide Benefits on Obesity, Hyperglycemia, and NAFL

ZHONG CHEN, MAOMAO GAO, XINYUE ZHAO, ZHIYING LI, JING ZHAO, CUNXIANG JU, XIANG GAO

Diabetes 2023;72(Supplement_1):1678-P

https://doi.org/10.2337/db23-1678-P

Published: 20 June 2023

View article titled, 1678-P: B6-Alms1-del Mice, a Metabolic Syndrome Animal Model, Shows Semaglutide Benefits on Obesity, Hyperglycemia, and NAFL

Meeting Abstracts

457-P: Ceramides and the Ceramide-Based Risk Scores CERT1 and CERT2 Are Elevated in Patients with the Metabolic Syndrome

THOMAS PLATTNER, CHRISTOPH H. SAELY, AXEL MUENDLEIN, ALEXANDER VONBANK, ARTHUR MADER, LUKAS SPRENGER, MAXIMILIAN MAECHLER, BARBARA LARCHER, HEINZ DREXEL, ANDREAS LEIHERER

Diabetes 2023;72(Supplement_1):457-P

https://doi.org/10.2337/db23-457-P

Published: 20 June 2023

View article titled, 457-P: Ceramides and the Ceramide-Based Risk Scores CERT1 and CERT2 Are Elevated in Patients with the Metabolic Syndrome

Meeting Abstracts

1705-P: Expression of Selected MicroRNAs in Adipose Tissue-Derived Mesenchymal Stem Cells and Metabolic Syndrome

GRZEGORZ WYSTRYCHOWSKI, KLAUDIA SIMKA-LAMPA, AGNIESZKA WITKOWSKA, EWELINA SOBECKO, ALEKSANDRA SKUBIS-SIKORA, BARTOSZ SIKORA, EWA WOJTYNA, KATARZYNA GWIZDEK, AGNIESZKA GOLDA, MARTA WRÓBEL, CELINA KRUSZNIEWSKA-RAJS, JOANNA GOLA

Diabetes 2023;72(Supplement_1):1705-P

https://doi.org/10.2337/db23-1705-P

Published: 20 June 2023

View article titled, 1705-P: Expression of Selected MicroRNAs in Adipose Tissue-Derived Mesenchymal Stem Cells and Metabolic Syndrome

Meeting Abstracts

1590-P: Post-Oral Glucose Load Hyperinsulinemia in Individuals with Metabolic Syndrome and Metabolic-Associated Fatty Liver Disease—First Steps toward the Development of Type 2 Diabetes?

GABRIELLE TRÉPANIER, THEO GIGNAC, MARION PRADEAU, ARIANNE MORISSETTE, ANNE-LAURE AGRINIER, CLAUDIA GAGNON, MARIE-CLAUDE VOHL, ANDRE MARETTE, ANNE-MARIE CARREAU

Diabetes 2023;72(Supplement_1):1590-P

https://doi.org/10.2337/db23-1590-P

Published: 20 June 2023

View article titled, 1590-P: Post-Oral Glucose Load Hyperinsulinemia in Individuals with Metabolic Syndrome and Metabolic-Associated Fatty Liver Disease—First Steps toward the Development of Type 2 Diabetes?

Meeting Abstracts

1586-P: Post-OGTT Low Blood Glucose in Individuals with Metabolic Syndrome, Metabolic Phenotypes, and Metabolic-Associated Fatty Liver Disease

THEO GIGNAC, ARIANNE MORISSETTE, ANNE-LAURE AGRINIER, CLAUDIA GAGNON, MARIE-CLAUDE VOHL, ANDRE MARETTE, ANNE-MARIE CARREAU

Diabetes 2023;72(Supplement_1):1586-P

https://doi.org/10.2337/db23-1586-P

Published: 20 June 2023

View article titled, 1586-P: Post-OGTT Low Blood Glucose in Individuals with Metabolic Syndrome, Metabolic Phenotypes, and Metabolic-Associated Fatty Liver Disease

Meeting Abstracts

1243-P: Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese

YURIE MITSUMA, KAZUYA FUJIHARA, KOSHIRO MURAI, TAKAAKI SATO, YUTA YAGUCHI, MAYUKO H. YAMADA, MASAHIKO YAMAMOTO, TAEKO OSAWA, MASARU KITAZAWA, YASUHIRO MATSUBAYASHI, MIDORI IWANAGA, TAKAHO YAMADA, KIMINORI KATO, HIROHITO SONE

Diabetes 2023;72(Supplement_1):1243-P

https://doi.org/10.2337/db23-1243-P

Published: 20 June 2023

View article titled, 1243-P: Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese

Meeting Abstracts

861-P: The Effect of Dual Amylin and Calcitonin Receptor Agonist Treatment on Spatial Memory in Rat Models of Metabolic Syndrome

KHALED ELHADY MOHAMED, ANNA T. LARSEN, SIMONE A. MELANDER, MORTEN A. KARSDAL, KIM HENRIKSEN

Diabetes 2023;72(Supplement_1):861-P

https://doi.org/10.2337/db23-861-P

Published: 20 June 2023

View article titled, 861-P: The Effect of Dual Amylin and Calcitonin Receptor Agonist Treatment on Spatial Memory in Rat Models of Metabolic Syndrome

Meeting Abstracts

431-P: Effects of CB1 Antagonist INV-202 in Patients with Metabolic Syndrome—A Randomized, Placebo-Controlled, Double-Blind Phase 1B Study

GLENN D. CRATER, FRANCOIS RAVENELLE, KARINE LALONDE, JEAN-PIERRE DESPRÉS

Diabetes 2023;72(Supplement_1):431-P

https://doi.org/10.2337/db23-431-P

Published: 20 June 2023

View article titled, 431-P: Effects of CB1 Antagonist INV-202 in Patients with Metabolic Syndrome—A Randomized, Placebo-Controlled, Double-Blind Phase 1B Study

Meeting Abstracts

1412-P: Sleep Patterns and Metabolic Syndrome Severity among African Americans in the Jackson Heart Study

DAISY DUAN, JONATHAN JUN, REXFORD AHIMA, ALAIN BERTONI, SUSAN REDLINE, JUSTIN ECHOUFFO TCHEUGUI

Diabetes 2023;72(Supplement_1):1412-P

https://doi.org/10.2337/db23-1412-P

Published: 20 June 2023

View article titled, 1412-P: Sleep Patterns and Metabolic Syndrome Severity among African Americans in the Jackson Heart Study

Journal Articles

Disentangling Genetic Risks for Metabolic Syndrome

Eva S. van Walree, Iris E. Jansen, Nathaniel Y. Bell, Jeanne E. Savage, Christiaan de Leeuw, Max Nieuwdorp, Sophie van der Sluis, Danielle Posthuma

Diabetes 2022;71(11):2447–2457

https://doi.org/10.2337/db22-0478

Published: 19 August 2022

View article titled, Disentangling Genetic Risks for Metabolic Syndrome

Meeting Abstracts

1196-P: Sex Difference in the Progression of Metabolic Syndrome Severity from Normoglycemia, Prediabetes, to Diabetes

YILIN YOSHIDA, ZHIPENG CHEN, ROBIN L. BAUDIER, MARIE KROUSEL-WOOD, AMANDA H. ANDERSON, VIVIAN FONSECA, FRANCK MAUVAIS-JARVIS

Diabetes 2022;71(Supplement_1):1196-P

https://doi.org/10.2337/db22-1196-P

Published: 01 June 2022

View article titled, 1196-P: Sex Difference in the Progression of Metabolic Syndrome Severity from Normoglycemia, Prediabetes, to Diabetes

NARROW

1787-PUB: An Increased Risk of Metabolic Syndrome in Type 2 Diabetes Mellitus Patients Is Suggested by a High TG/HDL Ratio—A Retrospective Study

1623-P: Identification of Gut Microbes That Prevents Metabolic Syndrome in Healthy Japanese Adults

321-OR: Differential Associations of Obesity and Metabolic Syndrome with Polyneuropathy in Early Type 2 Diabetes and Normal Glucose Tolerance

1538-P: Brain TGFß Regulates Glucose Tolerance in Male Mice with Metabolic Syndrome

1721-P: Patients with Metabolic Syndrome Are at Risk of Renal Outcome in CKD Stages 1-4 Regardless of Diabetes

1719-P: Nomogram for Predicting Remission of Metabolic Syndrome One Year after Sleeve Gastrectomy Surgery in Chinese Patients with Obesity

590-P: Assessment of a Comprehensive Physical Fitness Index to Predict Future Diabetes Mellitus (DM) and Metabolic Syndrome (MetS)

157-OR: Cystatin C Predicts Major Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients With and among Those Without the Metabolic Syndrome

1239-P: The Time Point of Blood Pressure Measurement Rather than the Application of U.S. vs. European Blood Pressure Categorizations Is Important for Cardiovascular Risk Prediction in Patients with the Metabolic Syndrome

1678-P: B6-Alms1-del Mice, a Metabolic Syndrome Animal Model, Shows Semaglutide Benefits on Obesity, Hyperglycemia, and NAFL

457-P: Ceramides and the Ceramide-Based Risk Scores CERT1 and CERT2 Are Elevated in Patients with the Metabolic Syndrome

1705-P: Expression of Selected MicroRNAs in Adipose Tissue-Derived Mesenchymal Stem Cells and Metabolic Syndrome

1590-P: Post-Oral Glucose Load Hyperinsulinemia in Individuals with Metabolic Syndrome and Metabolic-Associated Fatty Liver Disease—First Steps toward the Development of Type 2 Diabetes?

1586-P: Post-OGTT Low Blood Glucose in Individuals with Metabolic Syndrome, Metabolic Phenotypes, and Metabolic-Associated Fatty Liver Disease

1243-P: Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese

861-P: The Effect of Dual Amylin and Calcitonin Receptor Agonist Treatment on Spatial Memory in Rat Models of Metabolic Syndrome

431-P: Effects of CB1 Antagonist INV-202 in Patients with Metabolic Syndrome—A Randomized, Placebo-Controlled, Double-Blind Phase 1B Study

1412-P: Sleep Patterns and Metabolic Syndrome Severity among African Americans in the Jackson Heart Study

Disentangling Genetic Risks for Metabolic Syndrome

1196-P: Sex Difference in the Progression of Metabolic Syndrome Severity from Normoglycemia, Prediabetes, to Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only